Calico
Calico is an innovative research company focused on understanding and intervening in human aging and neurodegenerative diseases. They are looking for a highly skilled in vivo scientist to advance research on neurodegenerative disorders, especially Parkinson's disease, using rodent models to explore therapeutic interventions.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2013
Calico (Calico Life Sciences LLC) is an Alphabet-backed research and development company focused on understanding the biology of aging and translating that knowledge into interventions to extend healthy lifespan. The company combines large-scale biology, genetics, chemistry and computational approaches to discover targets, biomarkers and potential therapies for age-related diseases. Calico works through multi‑disciplinary teams and collaborations with academic and industry partners to move fundamental discoveries toward clinical impact.
AbbVie Ends 11-Year Relationship With Calico, Lays Off 100+
Nov 13, 2025
Calico, Alphabet’s anti-ageing play, goes it alone
Dec 12, 2025
Alphabet's Calico stitches $596M deal for Mabwell's anti-aging asset
Jun 26, 2025
Gold rush returns to California as thousands descend on tiny ghost town
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Calico .
30% above the average for this role
2 weeks ago